Suppr超能文献

微小RNA-193a-5p通过抑制波形蛋白和基质金属蛋白酶-9抑制人KATO III胃癌细胞的迁移能力。

microRNA-193a-5p Suppresses the Migratory Ability of Human KATO III Gastric Cancer Cells through Inhibition of Vimentin and MMP-9.

作者信息

Baghbanzadeh Amir, Baghbani Elham, Hajiasgharzadeh Khalil, Noorolyai Saeed, Khaze Vahid, Mansoori Behzad, Shirmohamadi Masoud, Baradaran Behzad, Mokhtarzadeh Ahad

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2022 Jan;12(1):169-175. doi: 10.34172/apb.2022.018. Epub 2020 Oct 19.

Abstract

is one of the well-known tumor suppressor miRNAs in the body but in many cases, its expression became reduced in patients suffering from gastric cancer (GC). The main purpose of this study was to restore the function of this miRNA in human GC cells and investigating the effects of enhanced expression of on proliferation, apoptosis, and migration of GC cells upon in vitro transfection. The KATO III GC cells were treated with 100 nM of or negative control sequences. Following that, the MTT assay, flow cytometry assay, and wound-healing assay were applied to estimate the impacts of enhanced expression of this miRNA on the viability, apoptosis, and migration rate of the cells, respectively. Moreover, the total RNA was isolated and alterations in the mRNA expression ratio of migratory genes were measured by qRT-PCR techniques. The findings designated that enhanced expression of suppressed the migratory ability of the cells, but had no significant effects on cell survival or apoptosis of the transfected cells. In addition, this inhibitory function of on the migration rate of the KATO III cell line occurs with concurrent suppression of vimentin and MMP-9 gene expression. It can be concluded that negatively influences the migratory ability of the cancerous cells and restoring its effects can be regarded as a promising target of future therapeutic interventions, especially for GC metastasis.

摘要

是体内著名的肿瘤抑制性微小RNA之一,但在许多情况下,其表达在胃癌(GC)患者中会降低。本研究的主要目的是在人GC细胞中恢复这种微小RNA的功能,并研究体外转染后其表达增强对GC细胞增殖、凋亡和迁移的影响。用100 nM的该微小RNA或阴性对照序列处理KATO III GC细胞。随后,分别应用MTT法、流式细胞术和伤口愈合试验来评估这种微小RNA表达增强对细胞活力、凋亡和迁移率的影响。此外,提取总RNA,并通过qRT-PCR技术测量迁移基因mRNA表达比率的变化。研究结果表明,该微小RNA表达增强抑制了细胞的迁移能力,但对转染细胞的存活或凋亡没有显著影响。此外,该微小RNA对KATO III细胞系迁移率的这种抑制作用伴随着波形蛋白和MMP-9基因表达的同时抑制。可以得出结论,该微小RNA对癌细胞的迁移能力有负面影响,恢复其作用可被视为未来治疗干预的一个有前景的靶点,尤其是对于GC转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1490/9012914/2edf8f135dd8/apb-12-169-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验